Dana-Farber colon cancer patient Dan Head and Dr. Matt Yurgelun on Dan’s genetic predisposition to colon cancer and advancements in genetic testing and management of hereditary cancer syndromes

WEEI/NESN Jimmy Fund Radio-Telethon
Wednesday, August 21st
Dan Head knew he had a genetic predisposition to cancer after his father was diagnosed with colon cancer and was on a preventative path leading up to his diagnosis—thus catching the cancer at an earlier, more treatable phase. Dr. Matt Yurgelun, director of the Lynch Syndrome Center at Dana-Farber joins Dan and OMF to discuss hereditary predispositions to cancer and his research.